Cargando…

Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities

Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Bios...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ming, Wang, Yong, Liu, Jinbiao, Huang, Zhixiang, Li, Xiangdong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148666/
https://www.ncbi.nlm.nih.gov/pubmed/32501433
http://dx.doi.org/10.1016/j.jobb.2018.12.011
_version_ 1783520640576258048
author Guo, Ming
Wang, Yong
Liu, Jinbiao
Huang, Zhixiang
Li, Xiangdong
author_facet Guo, Ming
Wang, Yong
Liu, Jinbiao
Huang, Zhixiang
Li, Xiangdong
author_sort Guo, Ming
collection PubMed
description Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Because of the in vivo work, the biosafety risk in ABSL-3 facilities is higher than that in BSL-3 facilities. Undoubtedly, management practices must be strengthened to ensure biosafety in the ABSL-3 facility. Meanwhile, we cannot ignore the reliable scientific results obtained from animal experiments conducted in ABSL-3 laboratories. It is of great practical significance to study the overall biosafety concepts that can increase the scientific data quality. Based on the management of animal experiments in the ABSL-3 Laboratory of Wuhan University, combined with relevant international and domestic literature, we indicate the main safety issues and factors affecting animal experiment results at ABSL-3 facilities. Based on these issues, management practices regarding animal experiments in ABSL-3 facilities are proposed, which take into account both biosafety and scientifically sound data.
format Online
Article
Text
id pubmed-7148666
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71486662020-04-13 Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities Guo, Ming Wang, Yong Liu, Jinbiao Huang, Zhixiang Li, Xiangdong J Biosaf Biosecur Article Animal models are crucial for the study of severe infectious diseases, which is essential for determining their pathogenesis and the development of vaccines and drugs. Animal experiments involving risk grade 3 agents such as SARS CoV, HIV, M.tb, H7N9, and Brucella must be conducted in an Animal Biosafety Level 3 (ABSL-3) facility. Because of the in vivo work, the biosafety risk in ABSL-3 facilities is higher than that in BSL-3 facilities. Undoubtedly, management practices must be strengthened to ensure biosafety in the ABSL-3 facility. Meanwhile, we cannot ignore the reliable scientific results obtained from animal experiments conducted in ABSL-3 laboratories. It is of great practical significance to study the overall biosafety concepts that can increase the scientific data quality. Based on the management of animal experiments in the ABSL-3 Laboratory of Wuhan University, combined with relevant international and domestic literature, we indicate the main safety issues and factors affecting animal experiment results at ABSL-3 facilities. Based on these issues, management practices regarding animal experiments in ABSL-3 facilities are proposed, which take into account both biosafety and scientifically sound data. Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. 2019-03 2019-02-20 /pmc/articles/PMC7148666/ /pubmed/32501433 http://dx.doi.org/10.1016/j.jobb.2018.12.011 Text en © 2019 Published by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Guo, Ming
Wang, Yong
Liu, Jinbiao
Huang, Zhixiang
Li, Xiangdong
Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title_full Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title_fullStr Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title_full_unstemmed Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title_short Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
title_sort biosafety and data quality considerations for animal experiments with highly infectious agents at absl-3 facilities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148666/
https://www.ncbi.nlm.nih.gov/pubmed/32501433
http://dx.doi.org/10.1016/j.jobb.2018.12.011
work_keys_str_mv AT guoming biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities
AT wangyong biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities
AT liujinbiao biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities
AT huangzhixiang biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities
AT lixiangdong biosafetyanddataqualityconsiderationsforanimalexperimentswithhighlyinfectiousagentsatabsl3facilities